Fox Chase Cancer Center

 

UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
M

Immunology & IO in Lynch Syndrome: Immune System, MSI & Hereditary Mismatch Deficiency, Current Therapies & Immuno-Prevention

By UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics FEATURING Michael J. Hall
By UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics FEATURING Michael J. Hall
114 views
February 16, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh
Videos
09:01

ASCO® GU 2025 Summary: Perioperative Strategies in MIBC - Key Trial …

Insights from 2025 ASCO® GU Annual Meeting

E. Plimack

216 views
09:27

Pirtobrutinib in R/R B-Cell Malignancies: Newest Data From the BRUIN…

Fox Chase Cancer Center

S. Nakhoda

75 views
06:32

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

2024 ESMO Annual Meeting Insights Hub

E. Plimack

232 views
12:50

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

755 views
04:25

LS-SCLC Updates - 2023 ASCO® Direct Philadelphia

Total Health

J. Bauman

83 views
04:35

Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…

Total Health

J. Bauman

234 views
26:42

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 ASCO® …

Total Health

J. Bauman

400 views
06:11

EHA® 2023 Insights: "An Outpatient Model for Teclistamab Step-Up Dos…

Insights from 2023 EHA® Annual Meeting

A. Varshavsky-Yanovsky

281 views
21:34

The Evolving Role of Dual Checkpoint Inhibition in Advanced NSCLC

2023 Texas Lung Cancer Conference Coverage

H. Borghaei

120 views
03:05

ASCO GU 2023 Adjuvant Therapies in Renal Cell Carcinoma: Are New Dat…

ASCO GU 2023 Conference Coverage

M. Zibelman

265 views
13:51

Adjuvant Treatment of NSCLC: ADAURA in Context

Fox Chase Cancer Center

M. Edelman

555 views
09:51

Influence of 1L Chemo on Survival Outcomes of Patients with Advanced…

Fox Chase Cancer Center

B. Miron

110 views
08:35

2L Treatment of Advanced Gastric Cancer: Moving Towards an Opportuni…

Fox Chase Cancer Center

N. Vijayvergia

416 views
19:53

2021 Update on Advanced Urothelial Cancer: Navigating 1L and Beyond …

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

E. Plimack

47 views
12:36

Genotype-Directed Therapy for Advanced NSCLC: Overview of Targeted T…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

542 views
13:52

Targeted Therapy for Advanced NSCLC: Efficacy Analysis of RET, KRAS,…

3rd Annual Atlanta Precision Oncology Symposium

H. Borghaei

38 views
34:34

Immunology & IO in Lynch Syndrome: Immune System, MSI & Hereditary M…

UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

M. J. Hall

114 views
16:08

Genomic Differentiation of Early-Onset CRC: When Should the Screenin…

Fox Chase Cancer Center

J. Meyer

331 views
08:15

2020 Update on Radiation Therapy in Lung Cancer: Is High-Dose Twice-…

2020 ASCO Virtual Direct™ Highlights

H. Borghaei

327 views
10:59

2020 ASCO Update on Targeted Therapy in NSCLC: Is Adjuvant Osimertin…

2020 ASCO Virtual Direct™ Highlights

H. Borghaei

440 views
03:24

2020 ASCO Update on Advanced RCC: Pembrolizumab + Axitinib vs. Sunit…

Fox Chase Cancer Center

E. Plimack

30 views
14:38

The Role of IO in Bladder Cancer: Potential Benefits in Neoadjuvant …

GRACE

E. Plimack, R. Sedhom

279 views
10:57

GI Cancer Risks Associated with Pathogenic Variants (PV) in the Atax…

23rd Collaborative Group of the Americas on Inherited Colorectal Cancer Annual Meeting

M. Hall

27 views
19:10

2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: …

Fox Chase Updates in Bladder and Kidney Cancer 2019

E. Plimack

445 views
14:23

Front Line Therapy in NSCLC: Immunotherapy vs Immunotherapy + Chemo?

Fox Chase Cancer Center

H. Borghaei

228 views
20:36

I-O/Chemo Combination Therapies in NSCLC

Fox Chase Cancer Center

H. Borghaei

298 views
09:14

Second Line Treatment Options in NSCLC

Fox Chase Cancer Center

H. Borghaei

394 views